Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2013

Conditions
Pain
Interventions
DRUG

Intravenous ibuprofen

800 mg intravenous ibuprofen administered intravenously over 5-10 minutes

Trial Locations (22)

11030

North Shore - Long Island Jewish Health System, Manhasset

11203

State of New York Downstate Medical Center (SUNY), Brooklyn

12208

Albany Medical Center, Albany

17033

Penn State College of Medicine, Hershey

19107

Thomas Jefferson University, Philadelphia

27157

Wake Forest Baptist Medical Center, Winston-Salem

27599

The University of North Carolina at Chapel Hill, Chapel Hill

27710

Duke University Health System, Durham

33136

University of Miami Health System, Miami

33324

Sheridan Clinical Research, Plantation

37075

Hendersonville Hospital/Comprehensive Pain Specialists, Hendersonville

38801

North Mississippi Sports Medicine & Orthopaedic Clinic, Tupelo

43201

The Ohio State University Medical Center, Columbus

44195

Cleveland Clinic, Cleveland

48201

Detroit Medical Center, Detroit

60612

RUSH Univ. Medical Center, Chicago

66160

Univ. of Kansas Medical Center, Kansas City

75235

Parkland Memorial, Dallas

92037

UC San Diego Regional Center, La Jolla

94558

Neurovations (Queen of the Valley Hospital), Napa

70121-2483

Ochsner Medical Center, New Orleans

02115

Brigham and Women's Hospital, Boston

Sponsors
All Listed Sponsors
lead

Cumberland Pharmaceuticals

INDUSTRY

NCT01334957 - Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen | Biotech Hunter | Biotech Hunter